These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28879565)

  • 1. Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.
    George Priya Doss C; Zayed H
    Metab Brain Dis; 2017 Dec; 32(6):2105-2118. PubMed ID: 28879565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural modeling of p.V31F variant in the aspartoacylase gene.
    Krishnamoorthy N; Zayed H
    Metab Brain Dis; 2016 Jun; 31(3):723-6. PubMed ID: 26797702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patients with Canavan disease and structural modeling of a novel mutation.
    Zaki OK; Krishnamoorthy N; El Abd HS; Harche SA; Mattar RA; Al Disi RS; Nofal MY; El Bekay R; Ahmed KA; George Priya Doss C; Zayed H
    Metab Brain Dis; 2017 Feb; 32(1):171-177. PubMed ID: 27531131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of aspartoacylase: implications for Canavan disease.
    Hershfield JR; Pattabiraman N; Madhavarao CN; Namboodiri MA
    Brain Res; 2007 May; 1148():1-14. PubMed ID: 17391648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartoacylase catalytic deficiency as the cause of Canavan disease: a structural perspective.
    Wijayasinghe YS; Pavlovsky AG; Viola RE
    Biochemistry; 2014 Aug; 53(30):4970-8. PubMed ID: 25003821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking, molecular dynamics and free energy studies on aspartoacylase mutations involved in Canavan disease.
    Kocak A; Yildiz M
    J Mol Graph Model; 2017 Jun; 74():44-53. PubMed ID: 28349879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Eke GH; Iscan A; Cece H; Calik M
    Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease.
    Mersmann N; Tkachev D; Jelinek R; Röth PT; Möbius W; Ruhwedel T; Rühle S; Weber-Fahr W; Sartorius A; Klugmann M
    PLoS One; 2011; 6(5):e20336. PubMed ID: 21625469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutation in an Egyptian patient with infantile Canavan disease.
    Zaki OK; El Abd HS; Mohamed SA; Zayed H
    Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of aspartoacylase (ASPA) and Canavan disease.
    Sommer A; Sass JO
    Gene; 2012 Sep; 505(2):206-10. PubMed ID: 22750302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
    Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
    J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
    Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
    J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.
    Mendes MI; Smith DE; Pop A; Lennertz P; Fernandez Ojeda MR; Kanhai WA; van Dooren SJ; Anikster Y; Barić I; Boelen C; Campistol J; de Boer L; Kariminejad A; Kayserili H; Roubertie A; Verbruggen KT; Vianey-Saban C; Williams M; Salomons GS
    Hum Mutat; 2017 May; 38(5):524-531. PubMed ID: 28101991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Nat8l Knockdown Suppresses Spongiform Leukodystrophy in an Aspartoacylase-Deficient Canavan Disease Mouse Model.
    Bannerman P; Guo F; Chechneva O; Burns T; Zhu X; Wang Y; Kim B; Singhal NK; McDonough JA; Pleasure D
    Mol Ther; 2018 Mar; 26(3):793-800. PubMed ID: 29456021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.
    Becker I; Wang-Eckhardt L; Eckhardt M
    J Inherit Metab Dis; 2024 Mar; 47(2):230-243. PubMed ID: 38011891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease.
    Sreevishnupriya K; Chandrasekaran P; Senthilkumar A; Sethumadhavan R; Shanthi V; Daisy P; Nisha J; Ramanathan K; Rajasekaran R
    Sci China Life Sci; 2012 Dec; 55(12):1109-19. PubMed ID: 23233226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
    Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
    Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan disease: studies on the knockout mouse.
    Matalon R; Michals-Matalon K; Surendran S; Tyring SK
    Adv Exp Med Biol; 2006; 576():77-93; discussion 361-3. PubMed ID: 16802706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system.
    Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S
    J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.